世界の臨床試験被験者募集市場インサイト及び予測(フェーズI、フェーズII、フェーズIII、フェーズIV)

◆英語タイトル:Global Patient Recruitment for Clinical Trials Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09269)◆商品コード:QY22JLX09269
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:129
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥705,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,058,400見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,411,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖
臨床試験被験者募集は、新しい治療法、薬剤、医療機器などの有効性や安全性を評価するために、特定の条件を持つ患者を選定し、試験に参加してもらうプロセスを指します。これは新薬の開発や治療法の検証において不可欠なステップであり、医療分野の進展に貢献しています。

臨床試験被験者募集の目的は、多くの患者からデータを収集し、試験対象となる治療法が実際に有効であるかどうかを明らかにすることです。これには、様々な疾患や状態を持つ患者が参加し、その反応を観察することが求められます。このデータは、最終的に新しい治療法が市場に出る際の承認申請や臨床ガイドラインの策定に影響を与えるため、非常に重要です。

被験者募集の特徴としては、いくつかの要因が挙げられます。まず、被験者は試験の目的に沿った特定の基準を満たす必要があります。これには、年齢、性別、既往歴、現在の健康状態などが含まれ、一定の基準を満たさない患者は試験に参加できない場合があります。また、被験者の募集には倫理的な配慮が必要です。すべての参加者は、試験の目的と内容について十分に説明を受け、同意を得ることが求められます。このプロセスは「インフォームド・コンセント」と呼ばれ、患者が自らの意思で参加を決定することを尊重します。

被験者募集にはいくつかの種類があります。主な種類としては、一般的な募集、特定の疾患に特化した募集、早期アクセスプログラムを利用した募集などがあります。一般的な募集は広範囲にわたって行われることが多く、異なる疾患群からの参加者を募る方法です。一方、特定の疾患に特化した募集は、特定の病状に苦しむ患者をターゲットにして行います。早期アクセスプログラムは、実際の治療に必要な患者が治療を受けるための特別な手段であり、特定の条件を満たす患者に限られます。

臨床試験被験者の募集には、多くの手法が用いられます。広告や宣伝、医療機関での情報提供、オンラインプラットフォームの活用、患者団体との連携などが一般的です。これにより、使用可能な被験者のプールが広がり、多様なデータを収集することが可能となります。また、最近ではSNS(ソーシャルネットワーキングサービス)やWeb広告を活用して、より広範なリーチを目指すケースも増えています。

さらに、関連技術の視点から見ると、臨床試験被験者募集はテクノロジーの進化によって変化しています。デジタルヘルス技術やAI(人工知能)の利用が進み、被験者の選定や募集プロセスが効率化されています。AIを利用すると、試験に合致する可能性の高い患者の特定が迅速に行えるため、募集期間を短縮し、効率的な試験運営が可能になります。

また、電子化された患者データベースやレジストリも重要な役割を果たしています。これらのデータベースには、特定の疾患を持つ患者の情報が蓄積されており、研究チームはこれを参考にしながら被験者を募集することができます。このように、技術の進化が臨床試験の効率性を高める一方で、患者プライバシーの保護やデータセキュリティも重要な課題です。倫理的に適切な方法でデータを扱うことが求められます。

最後に、臨床試験被験者の募集には、医療の質や患者の選択肢を広げる大きな意義があります。新しい治療法や医療技術の開発は、患者にとっての新たな希望となることがありますが、そのためには適切な被験者募集が欠かせません。医療技術の進歩に伴い、臨床試験の重要性は今後益々高まるでしょう。そのため、今後の臨床試験における被験者募集の方法や倫理、技術の進展を注視していく必要があります。
COVID-19のパンデミックにより、臨床試験被験者募集のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に臨床試験被験者募集の世界市場のxxx%を占める「フェーズI」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「呼吸器疾患」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
臨床試験被験者募集の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの臨床試験被験者募集市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

臨床試験被験者募集のグローバル主要企業には、Antidote、Clara Health、Clariness、BBK Worldwide、Worldwide Clinical Trials、Clinical Site Services (CCSi)、IQVIA、PPD Inc、Veristat、Elligo Health Research、AutoCruitment、Clinical Connection、Biorasi、Curavit Clinical Research、PatientEvolution、Praxis、MMG、Science37、StudyKIK、Global AES、TrialSpark、WCG ThreeWire、Trialfacts、Shanghai Jsureなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

臨床試験被験者募集市場は、種類と用途によって区分されます。世界の臨床試験被験者募集市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
フェーズI、フェーズII、フェーズIII、フェーズIV

【用途別セグメント】
呼吸器疾患、痛み&麻酔、腫瘍、中枢神経系、循環器、内分泌、抗感染症、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 臨床試験被験者募集製品概要
- 種類別市場(フェーズI、フェーズII、フェーズIII、フェーズIV)
- 用途別市場(呼吸器疾患、痛み&麻酔、腫瘍、中枢神経系、循環器、内分泌、抗感染症、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の臨床試験被験者募集販売量予測2017-2028
- 世界の臨床試験被験者募集売上予測2017-2028
- 臨床試験被験者募集の地域別販売量
- 臨床試験被験者募集の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別臨床試験被験者募集販売量
- 主要メーカー別臨床試験被験者募集売上
- 主要メーカー別臨床試験被験者募集価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(フェーズI、フェーズII、フェーズIII、フェーズIV)
- 臨床試験被験者募集の種類別販売量
- 臨床試験被験者募集の種類別売上
- 臨床試験被験者募集の種類別価格
・用途別市場規模(呼吸器疾患、痛み&麻酔、腫瘍、中枢神経系、循環器、内分泌、抗感染症、その他)
- 臨床試験被験者募集の用途別販売量
- 臨床試験被験者募集の用途別売上
- 臨床試験被験者募集の用途別価格
・北米市場
- 北米の臨床試験被験者募集市場規模(種類別、用途別)
- 主要国別の臨床試験被験者募集市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの臨床試験被験者募集市場規模(種類別、用途別)
- 主要国別の臨床試験被験者募集市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の臨床試験被験者募集市場規模(種類別、用途別)
- 主要国別の臨床試験被験者募集市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の臨床試験被験者募集市場規模(種類別、用途別)
- 主要国別の臨床試験被験者募集市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの臨床試験被験者募集市場規模(種類別、用途別)
- 主要国別の臨床試験被験者募集市場規模(トルコ、サウジアラビア)
・企業情報
Antidote、Clara Health、Clariness、BBK Worldwide、Worldwide Clinical Trials、Clinical Site Services (CCSi)、IQVIA、PPD Inc、Veristat、Elligo Health Research、AutoCruitment、Clinical Connection、Biorasi、Curavit Clinical Research、PatientEvolution、Praxis、MMG、Science37、StudyKIK、Global AES、TrialSpark、WCG ThreeWire、Trialfacts、Shanghai Jsure
・産業チェーン及び販売チャネル分析
- 臨床試験被験者募集の産業チェーン分析
- 臨床試験被験者募集の原材料
- 臨床試験被験者募集の生産プロセス
- 臨床試験被験者募集の販売及びマーケティング
- 臨床試験被験者募集の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 臨床試験被験者募集の産業動向
- 臨床試験被験者募集のマーケットドライバー
- 臨床試験被験者募集の課題
- 臨床試験被験者募集の阻害要因
・主な調査結果

Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients for your trial. The global market has noticed significant growth owing to the increasing rate of clinical trials, and the rapid growth of the medical and pharmaceutical industries.
Market Analysis and Insights: Global Patient Recruitment for Clinical Trials Market
The global Patient Recruitment for Clinical Trials market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Phase I accounting for % of the Patient Recruitment for Clinical Trials global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Respiratory Diseases segment is altered to an % CAGR throughout this forecast period.
China Patient Recruitment for Clinical Trials market size is valued at US$ million in 2021, while the North America and Europe Patient Recruitment for Clinical Trials are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Patient Recruitment for Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Patient Recruitment for Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Patient Recruitment for Clinical Trials market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Patient Recruitment for Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Patient Recruitment for Clinical Trials market.
Global Patient Recruitment for Clinical Trials Scope and Market Size
Patient Recruitment for Clinical Trials market is segmented by players, region (country), by Phase and by Application. Players, stakeholders, and other participants in the global Patient Recruitment for Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Phase and by Application for the period 2017-2028.
Segment by Phase
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Endocrine
Anti-Infective
Others
By Company
Antidote
Clara Health
Clariness
BBK Worldwide
Worldwide Clinical Trials
Clinical Site Services (CCSi)
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Praxis
MMG
Science37
StudyKIK
Global AES
TrialSpark
WCG ThreeWire
Trialfacts
Shanghai Jsure
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Phase
1.2.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Phase, 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Respiratory Diseases
1.3.3 Pain and Anesthesia
1.3.4 Oncology
1.3.5 Central Nervous System
1.3.6 Cardiovascular
1.3.7 Endocrine
1.3.8 Anti-Infective
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Recruitment for Clinical Trials Market Perspective (2017-2028)
2.2 Patient Recruitment for Clinical Trials Growth Trends by Region
2.2.1 Patient Recruitment for Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Patient Recruitment for Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 Patient Recruitment for Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 Patient Recruitment for Clinical Trials Market Dynamics
2.3.1 Patient Recruitment for Clinical Trials Industry Trends
2.3.2 Patient Recruitment for Clinical Trials Market Drivers
2.3.3 Patient Recruitment for Clinical Trials Market Challenges
2.3.4 Patient Recruitment for Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue
3.1.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global Patient Recruitment for Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient Recruitment for Clinical Trials Revenue
3.4 Global Patient Recruitment for Clinical Trials Market Concentration Ratio
3.4.1 Global Patient Recruitment for Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Recruitment for Clinical Trials Revenue in 2021
3.5 Patient Recruitment for Clinical Trials Key Players Head office and Area Served
3.6 Key Players Patient Recruitment for Clinical Trials Product Solution and Service
3.7 Date of Enter into Patient Recruitment for Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Recruitment for Clinical Trials Breakdown Data by Phase
4.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Phase (2017-2022)
4.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Phase (2023-2028)
5 Patient Recruitment for Clinical Trials Breakdown Data by Application
5.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Patient Recruitment for Clinical Trials Market Size (2017-2028)
6.2 North America Patient Recruitment for Clinical Trials Market Size by Phase
6.2.1 North America Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
6.2.2 North America Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
6.2.3 North America Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
6.3 North America Patient Recruitment for Clinical Trials Market Size by Application
6.3.1 North America Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
6.3.2 North America Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
6.3.3 North America Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
6.4 North America Patient Recruitment for Clinical Trials Market Size by Country
6.4.1 North America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
6.4.2 North America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Patient Recruitment for Clinical Trials Market Size (2017-2028)
7.2 Europe Patient Recruitment for Clinical Trials Market Size by Phase
7.2.1 Europe Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
7.2.2 Europe Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
7.2.3 Europe Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
7.3 Europe Patient Recruitment for Clinical Trials Market Size by Application
7.3.1 Europe Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
7.3.2 Europe Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
7.3.3 Europe Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
7.4 Europe Patient Recruitment for Clinical Trials Market Size by Country
7.4.1 Europe Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
7.4.2 Europe Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase
8.2.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
8.2.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
8.2.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
8.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application
8.3.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
8.4 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region
8.4.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Patient Recruitment for Clinical Trials Market Size (2017-2028)
9.2 Latin America Patient Recruitment for Clinical Trials Market Size by Phase
9.2.1 Latin America Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
9.2.2 Latin America Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
9.2.3 Latin America Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
9.3 Latin America Patient Recruitment for Clinical Trials Market Size by Application
9.3.1 Latin America Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
9.3.2 Latin America Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
9.3.3 Latin America Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
9.4 Latin America Patient Recruitment for Clinical Trials Market Size by Country
9.4.1 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
9.4.2 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase
10.2.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
10.2.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
10.2.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
10.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application
10.3.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
10.4 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country
10.4.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Antidote
11.1.1 Antidote Company Details
11.1.2 Antidote Business Overview
11.1.3 Antidote Patient Recruitment for Clinical Trials Introduction
11.1.4 Antidote Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.1.5 Antidote Recent Developments
11.2 Clara Health
11.2.1 Clara Health Company Details
11.2.2 Clara Health Business Overview
11.2.3 Clara Health Patient Recruitment for Clinical Trials Introduction
11.2.4 Clara Health Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.2.5 Clara Health Recent Developments
11.3 Clariness
11.3.1 Clariness Company Details
11.3.2 Clariness Business Overview
11.3.3 Clariness Patient Recruitment for Clinical Trials Introduction
11.3.4 Clariness Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.3.5 Clariness Recent Developments
11.4 BBK Worldwide
11.4.1 BBK Worldwide Company Details
11.4.2 BBK Worldwide Business Overview
11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Introduction
11.4.4 BBK Worldwide Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.4.5 BBK Worldwide Recent Developments
11.5 Worldwide Clinical Trials
11.5.1 Worldwide Clinical Trials Company Details
11.5.2 Worldwide Clinical Trials Business Overview
11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Introduction
11.5.4 Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.5.5 Worldwide Clinical Trials Recent Developments
11.6 Clinical Site Services (CCSi)
11.6.1 Clinical Site Services (CCSi) Company Details
11.6.2 Clinical Site Services (CCSi) Business Overview
11.6.3 Clinical Site Services (CCSi) Patient Recruitment for Clinical Trials Introduction
11.6.4 Clinical Site Services (CCSi) Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.6.5 Clinical Site Services (CCSi) Recent Developments
11.7 IQVIA
11.7.1 IQVIA Company Details
11.7.2 IQVIA Business Overview
11.7.3 IQVIA Patient Recruitment for Clinical Trials Introduction
11.7.4 IQVIA Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.7.5 IQVIA Recent Developments
11.8 PPD Inc
11.8.1 PPD Inc Company Details
11.8.2 PPD Inc Business Overview
11.8.3 PPD Inc Patient Recruitment for Clinical Trials Introduction
11.8.4 PPD Inc Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.8.5 PPD Inc Recent Developments
11.9 Veristat
11.9.1 Veristat Company Details
11.9.2 Veristat Business Overview
11.9.3 Veristat Patient Recruitment for Clinical Trials Introduction
11.9.4 Veristat Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.9.5 Veristat Recent Developments
11.10 Elligo Health Research
11.10.1 Elligo Health Research Company Details
11.10.2 Elligo Health Research Business Overview
11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Introduction
11.10.4 Elligo Health Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.10.5 Elligo Health Research Recent Developments
11.11 AutoCruitment
11.11.1 AutoCruitment Company Details
11.11.2 AutoCruitment Business Overview
11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Introduction
11.11.4 AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.11.5 AutoCruitment Recent Developments
11.12 Clinical Connection
11.12.1 Clinical Connection Company Details
11.12.2 Clinical Connection Business Overview
11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Introduction
11.12.4 Clinical Connection Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.12.5 Clinical Connection Recent Developments
11.13 Biorasi
11.13.1 Biorasi Company Details
11.13.2 Biorasi Business Overview
11.13.3 Biorasi Patient Recruitment for Clinical Trials Introduction
11.13.4 Biorasi Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.13.5 Biorasi Recent Developments
11.14 Curavit Clinical Research
11.14.1 Curavit Clinical Research Company Details
11.14.2 Curavit Clinical Research Business Overview
11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Introduction
11.14.4 Curavit Clinical Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.14.5 Curavit Clinical Research Recent Developments
11.15 PatientEvolution
11.15.1 PatientEvolution Company Details
11.15.2 PatientEvolution Business Overview
11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Introduction
11.15.4 PatientEvolution Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.15.5 PatientEvolution Recent Developments
11.16 Praxis
11.16.1 Praxis Company Details
11.16.2 Praxis Business Overview
11.16.3 Praxis Patient Recruitment for Clinical Trials Introduction
11.16.4 Praxis Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.16.5 Praxis Recent Developments
11.17 MMG
11.17.1 MMG Company Details
11.17.2 MMG Business Overview
11.17.3 MMG Patient Recruitment for Clinical Trials Introduction
11.17.4 MMG Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.17.5 MMG Recent Developments
11.18 Science37
11.18.1 Science37 Company Details
11.18.2 Science37 Business Overview
11.18.3 Science37 Patient Recruitment for Clinical Trials Introduction
11.18.4 Science37 Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.18.5 Science37 Recent Developments
11.19 StudyKIK
11.19.1 StudyKIK Company Details
11.19.2 StudyKIK Business Overview
11.19.3 StudyKIK Patient Recruitment for Clinical Trials Introduction
11.19.4 StudyKIK Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.19.5 StudyKIK Recent Developments
11.20 Global AES
11.20.1 Global AES Company Details
11.20.2 Global AES Business Overview
11.20.3 Global AES Patient Recruitment for Clinical Trials Introduction
11.20.4 Global AES Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.20.5 Global AES Recent Developments
11.21 TrialSpark
11.21.1 TrialSpark Company Details
11.21.2 TrialSpark Business Overview
11.21.3 TrialSpark Patient Recruitment for Clinical Trials Introduction
11.21.4 TrialSpark Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.21.5 TrialSpark Recent Developments
11.22 WCG ThreeWire
11.22.1 WCG ThreeWire Company Details
11.22.2 WCG ThreeWire Business Overview
11.22.3 WCG ThreeWire Patient Recruitment for Clinical Trials Introduction
11.22.4 WCG ThreeWire Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.22.5 WCG ThreeWire Recent Developments
11.23 Trialfacts
11.23.1 Trialfacts Company Details
11.23.2 Trialfacts Business Overview
11.23.3 Trialfacts Patient Recruitment for Clinical Trials Introduction
11.23.4 Trialfacts Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.23.5 Trialfacts Recent Developments
11.24 Shanghai Jsure
11.24.1 Shanghai Jsure Company Details
11.24.2 Shanghai Jsure Business Overview
11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Introduction
11.24.4 Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.24.5 Shanghai Jsure Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の臨床試験被験者募集市場インサイト及び予測(フェーズI、フェーズII、フェーズIII、フェーズIV)(Global Patient Recruitment for Clinical Trials Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。